Compare NNNN & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | CTS |
|---|---|---|
| Founded | 2021 | 1896 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 1994 |
| Metric | NNNN | CTS |
|---|---|---|
| Price | $28.44 | $54.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.8K | ★ 146.6K |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ 15.87 |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $541,318,000.00 |
| Revenue This Year | N/A | $5.55 |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | $446.57 | ★ $25.01 |
| Revenue Growth | N/A | ★ 4.95 |
| 52 Week Low | $6.05 | $36.03 |
| 52 Week High | $55.65 | $59.66 |
| Indicator | NNNN | CTS |
|---|---|---|
| Relative Strength Index (RSI) | 62.00 | 65.50 |
| Support Level | $26.48 | $40.69 |
| Resistance Level | $30.70 | $59.66 |
| Average True Range (ATR) | 2.14 | 1.59 |
| MACD | 0.36 | 0.80 |
| Stochastic Oscillator | 77.37 | 83.21 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.